->Gab4gab: /* Selected Awards and Honors */ sentence case heading

2021-10-17T19:08:07Z

Selected Awards and Honors: sentence case heading

New page

{{short description|Indian economist and an epidemiologist}}
'''Ramanan Laxminarayan''' Ph.D., M.P.H is an economist and an [[epidemiologist]]. He is founder and director of the [[Center for Disease Dynamics, Economics & Policy]] (CDDEP) in Washington, D.C. and senior research scholar at [[Princeton University]], an affiliate professor at the [[University of Washington]]. His research on [[epidemiological models]] of infectious diseases and economic analysis of [[drug resistance]] on public health gets attention from leaders and policymakers worldwide.<ref name="What India Needs to Fight the Virus">{{cite news |title=What India Needs to Fight the Virus |url=https://www.nytimes.com/2020/03/27/opinion/india-coronavirus-lockdown.html |accessdate=26 April 2020 |publisher=The New York Times |date=March 27, 2020}}</ref> He served on the President [[Barack Obama|Obama's]] [[Council of Advisors on Science and Technology]]’s antimicrobial resistance working group. He is also a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance.<ref name="Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria">{{cite web |title=Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria |url=https://www.hhs.gov/ash/advisory-committees/paccarb/membership/index.html |publisher=Assistant Secretary for Health Department of Health and Human Services Washington, DC |accessdate=26 April 2020}}</ref> He is a chairperson of the Global Antibiotic Research and Development Partnership (GARDP), a not-for-profit organization created by the [[World Health Organization]] along with [[Drugs for Neglected Diseases Initiative]] (DNDi).<ref name="Untreatable Gonorrhea on the Rise Worldwide">{{cite news |last1=Maxmen |first1=Amy |title=Untreatable Gonorrhea on the Rise Worldwide |url=https://www.scientificamerican.com/article/untreatable-gonorrhea-on-the-rise-worldwide/ |accessdate=26 April 2020 |publisher=Nature magazine |date=July 7, 2017}}</ref><ref name="C V OF RAMANAN LAXMINARAYAN">{{cite web |title=C V OF RAMANAN LAXMINARAYAN |url=https://cddep.org/wp-content/uploads/2017/06/CV_ramanan.pdf |website=https://cddep.org/ |accessdate=27 April 2020}}</ref>

Laxminarayan was a key architect of the Affordable Medicines Facility-malaria (AMFm), an innovative financing mechanism to provide affordable, effective antimalarial drugs worldwide.<ref>{{Cite journal|last=Laxminarayan|first=Ramanan|last2=Gelband|first2=Hellen|date=July 2009|title=A global subsidy: key to affordable drugs for malaria?|url=https://pubmed.ncbi.nlm.nih.gov/19597193/|journal=Health Affairs (Project Hope)|volume=28|issue=4|pages=949–961|doi=10.1377/hlthaff.28.4.949|issn=1544-5208|pmid=19597193|doi-access=free}}</ref> The idea emerged from an Institute of Medicine panel chaired by economist Kenneth Arrow that called for global subsidies to ensure that artemisinin-based antimalarials were introduced to crowd out monotherapies that would result in resistance.<ref>{{Cite book|last=Medicine|first=Institute of|url=https://www.nap.edu/catalog/11017/saving-lives-buying-time-economics-of-malaria-drugs-in-an|title=Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance|date=2004-07-20|isbn=978-0-309-09218-0|language=en}}</ref> Laxminarayan served on that panel and subsequently worked extensively on the design of the subsidy mechanism.<ref>{{Cite journal|last=Laxminarayan|first=Ramanan|last2=Parry|first2=Ian W. H.|last3=Smith|first3=David L.|last4=Klein|first4=Eili Y.|date=2010-05-01|title=Should new antimalarial drugs be subsidized?|url=http://www.sciencedirect.com/science/article/pii/S0167629610000433|journal=Journal of Health Economics|language=en|volume=29|issue=3|pages=445–456|doi=10.1016/j.jhealeco.2010.03.002|issn=0167-6296}}</ref><ref>{{Cite journal|last=Laxminarayan|first=Ramanan|last2=Arrow|first2=Kenneth|last3=Jamison|first3=Dean|last4=Bloom|first4=Barry R.|date=2012-11-02|title=From Financing to Fevers: Lessons of an Antimalarial Subsidy Program|url=https://science.sciencemag.org/content/338/6107/615|journal=Science|language=en|volume=338|issue=6107|pages=615–616|doi=10.1126/science.1231010|issn=0036-8075|pmid=23118173}}</ref> AMFm was launched in 2008 with a commitment from British Prime Minister Gordon Brown.<ref>{{Cite journal|last=Laxminarayan|first=Ramanan|last2=Gelband|first2=Hellen|date=July 2009|title=A Global Subsidy: Key To Affordable Drugs For Malaria?|url=http://www.healthaffairs.org/doi/10.1377/hlthaff.28.4.949|journal=Health Affairs|language=en|volume=28|issue=4|pages=949–961|doi=10.1377/hlthaff.28.4.949|issn=0278-2715|doi-access=free}}</ref>

He is a leading global expert on understanding of antibiotic resistance as a problem of managing a shared global resource. Through his prolific research, active public outreach and sustained policy engagement, Laxminarayan played a central role in bringing the issue of drug resistance to the attention of leaders and policymakers worldwide and to the United Nations General Assembly in September 2016.<ref>{{Cite journal|last=Jørgensen|first=Peter S.|last2=Wernli|first2=Didier|last3=Carroll|first3=Scott P.|last4=Dunn|first4=Robert R.|last5=Harbarth|first5=Stephan|last6=Levin|first6=Simon A.|last7=So|first7=Anthony D.|last8=Schlüter|first8=Maja|last9=Laxminarayan|first9=Ramanan|date=2016-09-08|title=Use antimicrobials wisely|url=http://www.nature.com/news/use-antimicrobials-wisely-1.20534|journal=Nature News|language=en|volume=537|issue=7619|pages=159|doi=10.1038/537159a|doi-access=free}}</ref><ref>{{Cite journal|last=Laxminarayan|first=Ramanan|last2=Sridhar|first2=Devi|last3=Blaser|first3=Martin|last4=Wang|first4=Minggui|last5=Woolhouse|first5=Mark|date=2016-08-26|title=Achieving global targets for antimicrobial resistance|url=https://science.sciencemag.org/content/353/6302/874|journal=Science|language=en|volume=353|issue=6302|pages=874–875|doi=10.1126/science.aaf9286|issn=0036-8075|pmid=27540009|hdl=20.500.11820/34211550-a24c-4a47-a0f0-128c404f2176|hdl-access=free}}</ref> His TED talk on antibiotic resistance which helped bring attention to this issue has been viewed more than a million times.<ref>{{Citation|last=Laxminarayan|first=Ramanan|title=The coming crisis in antibiotics|url=https://www.ted.com/talks/ramanan_laxminarayan_the_coming_crisis_in_antibiotics|language=en|access-date=2020-08-12}}</ref>

During the Obama Administration, Laxminarayan served on the U.S. President’s Council of Advisors on Science and Technology’s antimicrobial resistance working group.<ref>[https://www.cdc.gov/drugresistance/pdf/report-to-the-president-on-combating-antibiotic-resistance.pdf Members of PCAST Antibiotic Resistance Working Group]</ref> He was subsequently appointed a voting member of the U.S. Presidential Advisory Council on Combating Antimicrobial Resistance in 2016.<ref>{{Cite web|last=Health (ASH)|first=Assistant Secretary for|date=2016-02-08|title=Voting Member (SGE): Ramanan Laxminarayan, PhD, MPH|url=https://www.hhs.gov/ash/advisory-committees/paccarb/membership/voting-member-ramanan-laxminarayan/index.html|access-date=2020-08-12|website=HHS.gov|language=en}}</ref>

In 2012, Laxminarayan created the Immunization Technical Support Unit that supports the immunization program of the Ministry of Health and Family Welfare of the Government of India and which is credited with helping rapidly improve vaccination coverage and introduction of four new vaccines.<ref>{{Cite news|last=Delhi|date=2015-03-23|title=Health Minister Shri J P Nadda launches Media Campaign for 'Mission Indradhanush' Seeks cooperation of various stakeholders in creating awareness and generating support for full immunization of all children|work=Business Standard India|url=https://www.business-standard.com/article/government-press-release/health-minister-shri-j-p-nadda-launches-media-campaign-for-mission-115032300731_1.html|access-date=2020-08-12}}</ref> He is a series editor of the Disease Control Priorities for Developing Countries, 3rd edition.<ref>{{Cite web|title=Ramanan Laxminarayan {{!}} DCP3|url=http://dcp-3.org/editor/ramanan-laxminarayan|access-date=2020-08-12|website=dcp-3.org}}</ref>
== Selected awards and honors ==
Distinguished Alumnus, Academia and Research, Birla Institute of Technology and Science, Pilani, 2019<ref>Distinguished Alumnus, Academia and Research, Birla Institute of Technology and Science, Pilani [https://www.bits-pilani.ac.in/Uploads/University_Upload/Alumni/DAA2019/Distinguished-Alumni-Awards-2019.pdf]</ref>

Distinguished Alumnus, University of Washington, Seattle, 2020<ref>{{Cite web|title=Ramanan Laxminarayan - Our 2020 Distinguished Alumnus{{!}} Department of Economics{{!}} University of Washington|url=https://econ.washington.edu/news/2020/04/01/ramanan-laxminarayan-our-2020-distinguished-alumnus|access-date=2020-08-12|website=econ.washington.edu}}</ref>

Ella Pringle Keynote Lecture Medal, Royal College of Physicians of Edinburgh 2018<ref>{{Cite web|title=https://twitter.com/rcpedin/status/1007233150894903296|url=https://twitter.com/rcpedin/status/1007233150894903296|access-date=2020-08-12|website=Twitter|language=en}}</ref>

Winter Lecture, 2015, University of Edinburgh<ref>{{Cite web|title=Further Seminars and Events|url=https://www.ed.ac.uk/global-health/news-events/events/further-seminars|access-date=2020-08-12|website=The University of Edinburgh|language=en}}</ref>

BP Koirala Memorial Oration, BP Koirala Institute of Health Sciences, Dharan, 2019<ref>Ramanan Laxminarayan received the BP Koirala Medal and delivered the BP Koirala Memorial Oration in honor of Nepal’s first democratically elected Prime Minister.[https://chw.princeton.edu/sites/chw2017/files/resource-links/chw_2019_annual_report.pdf]</ref>
----

==References==
{{reflist}}

{{Authority control}}

{{DEFAULTSORT:Laxminarayan, Ramanan}}
[[Category:Indian economists]]
[[Category:Indian epidemiologists]]
[[Category:Birla Institute of Technology and Science, Pilani alumni]]
[[Category:Living people]]
[[Category:Year of birth missing (living people)]]

Ramanan Laxminarayan - Revision history

->Gab4gab: /* Selected Awards and Honors */ sentence case heading